Cybin Reaches New 52-Week High Heres Why
NMDBFDelisted Stock | USD 0.50 0.00 0.00% |
Roughly 56% of NeonMind Biosciences' investor base is looking to short. The analysis of overall sentiment of trading NeonMind Biosciences pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with NeonMind Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use NeonMind Biosciences stock news signals to limit their universe of possible portfolio assets.
NeonMind Biosciences pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of NeonMind daily returns and investor perception about the current price of NeonMind Biosciences as well as its diversification or hedging effects on your existing portfolios.
NeonMind |
Shares of Cybin Inc. hit a new 52-week high during trading on Tuesday . The company traded as high as 9.95 and last traded at 9.47, with a volume of 182862 shares traded. The stock had previously closed at 9.91. Cybin Price Performance The stocks 50-day moving average price is
Read at thelincolnianonline.com
NeonMind Biosciences Fundamental Analysis
We analyze NeonMind Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NeonMind Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NeonMind Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Gross Profit
Gross Profit Comparative Analysis
NeonMind Biosciences is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
NeonMind Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NeonMind Biosciences pink sheet to make a market-neutral strategy. Peer analysis of NeonMind Biosciences could also be used in its relative valuation, which is a method of valuing NeonMind Biosciences by comparing valuation metrics with similar companies.
Peers
NeonMind Biosciences Related Equities
CYBN | Cybin | 3.11 | ||||
DAWN | Day One | 2.65 | ||||
MNMD | Mind Medicine | 1.99 | ||||
ATAI | ATAI Life | 0.85 | ||||
FBIO | Fortress Biotech | 1.15 | ||||
TERN | Terns Pharmaceuticals | 3.14 | ||||
XFOR | X4 Pharmaceuticals | 4.69 | ||||
HOOK | Hookipa Pharma | 5.61 | ||||
GHRS | GH Research | 7.31 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in NeonMind Pink Sheet
If you are still planning to invest in NeonMind Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NeonMind Biosciences' history and understand the potential risks before investing.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |